Shanghai, China

Songliang Tan

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Shanghai Hansoh Biomedical Co., Ltd., Youngene Therapeutics Co., Ltd.. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Songliang Tan. Retrieved from https://idiyas.com/inventor/songliang-tan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.1

ph-index = 1


Location History:

  • Shanghai, CN (2019)
  • Jiangsu, CN (2018 - 2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Hello! I'm excited to share information with you about inventor Songliang Tan from Shanghai, CN. Let's dive into the details.

Title:

Innovator Spotlight: Songliang Tan - Pioneering Advances in Cancer Treatment

Introduction:

Songliang Tan, a distinguished inventor based in Shanghai, CN, has made significant contributions to the field of medicine through his groundbreaking patents and research endeavors. With a keen focus on developing innovative solutions for cancer treatment, Tan has garnered recognition for his cutting-edge work in the pharmaceutical industry.

Latest Patents:

Tan's latest patents showcase his expertise in creating novel therapies for cancer. One of his notable inventions includes the FGFR4 inhibitor, which demonstrates a potent inhibitory effect on FGFR4 kinase activity. This inhibitor has shown promising results in treating various cancers, such as liver cancer, stomach cancer, and prostate cancer. Additionally, Tan has pioneered the development of EGFR inhibitors, specifically targeting mutations associated with non-small cell lung cancer. His inventions offer new possibilities for enhancing cancer treatment outcomes.

Career Highlights:

Throughout his career, Tan has made significant strides in the pharmaceutical sector. He has been instrumental in shaping the research and development efforts at Shanghai Hansoh Biomedical Co., Ltd., and Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Tan's innovative approach to drug discovery has led to the creation of transformative therapies that hold great potential in improving patient care.

Collaborations:

Tan has collaborated with esteemed colleagues in his professional journey. Among his notable coworkers are Peng Gao and Guangjun Sun, who have collectively contributed to the success of various research projects and patent developments. Their collaborative efforts have fostered a culture of innovation and excellence within the pharmaceutical industry.

Conclusion:

In summary, Songliang Tan's inventive spirit and dedication to advancing cancer treatment have established him as a trailblazer in the field of medicine. His remarkable patents, successful career milestones, and collaborative ventures underscore his profound impact on the healthcare landscape. Tan's visionary work continues to inspire future generations of inventors and researchers in the pursuit of breakthrough therapies for combating cancer.

I hope you found this overview of Songliang Tan's achievements enlightening and inspiring! If you have any more inquiries or need further details, feel free to ask.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…